Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:14 PM
Ignite Modification Date:
2025-12-24 @ 1:14 PM
NCT ID:
NCT00413595
Eligibility Criteria:
Inclusion Criteria:
* Adult patients (18 - 55 years of age) with an acute cerebrovascular event (CVE) of any etiology defined as patients having an ischemic stroke or transient ischemic attack
* Genetic diagnosis (a-galactosidase defect)of Fabry disease
* Written informed consent from patient
Exclusion Criteria:
* No proven Fabry disease
* Participating in an other clinical trial with any investigational new drug or medical device
* Contraindication to any of the diagnostic procedures like e.g. MRI investigation
* Patient has been pretreated with Enzyme Replacement Therapy at the date of informed consent of sifap2
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT00413595
Study Brief:
Protocol Section:
NCT00413595